Synapse - Patrick Hilden

Results (108)

CMV seropositivity and viremia drive T-cell reconstitution after CD34-selected allogeneic HCT

Meeting Abstract

Cho, C.; Hilden, P.; Politikos, I.; Borrill, T.; Ciolino, C.; Devlin, S. M.; Maloy, M.; Smith, K.; Giralt, S. A.; O'Reilly, R. J.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Recipient CMV seropositivity & viremia is associated with the development of cord blood (CB) derived CD8+ effectors & effector memory cells in adults undergoing CB transplantation (CBT)

Meeting Abstract

Politikos, I.; Hilden, P.; Cho, C.; Borrill, T.; Ciolino, C.; Maloy, M.; Yoo, Y.; Smith, K.; Giralt, S. A.; Ponce, D. M.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Combining the disease risk index (DRI) and hematopoietic cell transplantation comorbidity index (HCT-CI) provides a comprehensive prognostic model for CD34-selected allogeneic HCT

Meeting Abstract

Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Maloy, M.; Meagher, R.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)

Meeting Abstract

Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
Blood (2017)

Fulltext@MSK | Save

Impact of omitting post-transplant mini-methotrexate doses in allogeneic hematopoietic cell transplantation: A single-center retrospective study

Meeting Abstract

Lin, A.; Hilden, P.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; Tamari, R.; Ponce, D.; Giralt, S. A.; Gyurkocza, B.
Blood (2017)

Fulltext@MSK | Save

A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies

Journal Article

Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Development of models to predict radiation dosimetric distribution in different regions of the jaw in patients receiving radiation therapy to the head and neck

Meeting Abstract

Tsai, C. J.; Owosho, A.; Hilden, P.; Yom, S.; Lee, N.; Huryn, J.; Estilo, C.
International Journal of Radiation Oncology, Biology, Physics (2017)

Fulltext@MSK | Save

Assessment of organ dosimetry for planning repeat treatments of high-dose (131)I-MIBG therapy: (123)I-MIBG versus posttherapy (131)I-MIBG imaging

Journal Article

Pandit-Taskar, N.; Zanzonico, P.; Hilden, P.; Ostrovnaya, I.; Carrasquillo, J. A.; Modak, S.
Clinical Nuclear Medicine (2017)

Fulltext@MSK | Save

T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic stem cell transplantation as curative therapy for hematologic malignancies